Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone affects hair loss, acne, and excessive hair growth, and antiandrogens can help treat these conditions.

Hair follicle regeneration possible, more research needed.

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

Mice with human gene experienced hair loss when treated with DHT.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Estrogens can reduce DHT production in hair follicles, but are less effective than finasteride and progesterone.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Apigenin may help promote hair growth and could treat hair loss.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Testosterone increases cell growth and reduces IL-6 in gum cells.

Antiandrogens help treat hormone-related conditions in both men and women.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

MK-386 lowers DHT in blood and skin but not in semen.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.